Rare HFE variants are the most frequent cause of hemochromatosis in non‐c282y homozygous patients with hemochromatosis-Reference-Cited by-同舟云学术

Rare HFE variants are the most frequent cause of hemochromatosis in non‐c282y homozygous patients with hemochromatosis

Published:2016-08-22 Issue:12 Volume:91 Page:1202-1205
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Hamdi‐Rozé Houda¹²,Beaumont‐Epinette Marie‐Pascale¹²,Ben Ali Zeineb¹³,Le Lan Caroline¹³,Loustaud‐Ratti Véronique¹⁴,Causse Xavier¹⁵,Loreal Olivier¹⁶,Deugnier Yves¹³,Brissot Pierre⁶,Jouanolle Anne‐Marie¹²,Bardou‐Jacquet Edouard¹³⁶^ORCID

Affiliation:

1. CHU Rennes, French Reference Centre for Rare Iron Overload Diseases of Genetic OriginRennes France

2. Molecular Genetics DepartmentCHU RennesRennes35000 France

3. Liver Disease DepartmentCHU RennesRennes35000 France

4. CHU Limoges Service d'Hépato‐gastroentérologie, U850 INSERM Univ LimogesF‐87000Limoges France

5. Hepatology and Gastroenterology departmentRegional Hospital of OrléansOrléans45000 France

6. University of Rennes1, Inserm UMR 991Rennes35000 France

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.24535

Reference19 articles.

1. EASL clinical practice guidelines for HFE hemochromatosis

2. Iron-Overload–Related Disease inHFEHereditary Hemochromatosis

3. Liver transplantation normalizes serum hepcidin level and cures iron metabolism alterations inHFEhemochromatosis

4. Iron overload in HFE C282Y heterozygotes at first genetic testing: a strategy for identifying rare HFE variants

5. The Clinical Relevance of Compound Heterozygosity for the C282Y and H63D Substitutions in Hemochromatosis

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular testing in hemochromatosis;Diagnostic Molecular Pathology;2024

2. Hereditary hemochromatosis;Comprehensive Guide to Hepatitis Advances;2023

3. A simple clinical score to promote and enhance ferroportin disease screening;Journal of Hepatology;2021-11

4. Hemochromatosis classification: update and recommendations by the BIOIRON Society;Blood;2021-10-03

5. Hyperferritinemia—A Clinical Overview;Journal of Clinical Medicine;2021-05-07